高级检索
当前位置: 首页 > 详情页

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100044, Peoples R China [2]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China [3]Peking Univ Hlth Sci Ctr, Beijing, Peoples R China [4]Henan Prov Peoples Hosp, Zhengzhou, Peoples R China [5]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China [6]Lanzhou Univ, Hosp 1, Lanzhou 730000, Peoples R China [7]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China [8]Shanghai Ruijin Hosp, Shanghai, Peoples R China [9]Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China [10]Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China [11]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China [12]Shandong Univ, Hosp 2, Jinan 250100, Peoples R China [13]Kunming Med Coll, Affiliated Hosp 1, Kunming, Peoples R China [14]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [15]Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China [16]Hubei Wuhan Univ, Peoples Hosp, Wuhan, Peoples R China [17]Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Tongji Hosp, Wuhan 430074, Peoples R China [18]Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China [19]Shanxi Med Univ, Affiliated Hosp 1, Taiyuan, Peoples R China [20]China Med Univ, Shengjing Hosp, Shenyang, Peoples R China [21]Jilin Univ, Hosp 1, Changchun 130023, Peoples R China [22]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310027, Peoples R China [23]Cent South Univ, Xiangya Hosp 2, Changsha 410083, Hunan, Peoples R China [24]Ningxia Peoples Hosp, Yinchuan, Peoples R China [25]Southwest Hosp, Chongqing, Peoples R China [26]West China Hosp, Chengdu, Peoples R China [27]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China [28]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [29]Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China [30]Bristol Myers Squibb Co, Wallingford, CT 06492 USA
出处:
ISSN:

关键词: China cirrhosis epidemiology HPV IL28B natural history

摘要:
Background and AimChronic hepatitis C virus (HCV) infection is relatively frequent in China. This study investigated the clinical, demographic, and viral and host genetic characteristics that may influence disease manifestations and clinical management. MethodsIn this cross-sectional observational study, treatment-naive Han ethnic adults with recently confirmed chronic HCV infection were enrolled at 28 hospitals across China. HCV genotype and host interleukin 28B (IL28B) genotypes were determined and compared with patient demographic parameters and medical status. ResultsAmong the 997 HCV-positive patients analyzed, 56.8% were infected with HCV genotype 1b, followed in prevalence by genotypes 2, 3, and 6, with substantial regional variation. Overall, 84.1% of patients were IL28B genotype CC (rs12979860), with little regional variation. Cirrhosis was reported in 10.1% of patients and was significantly associated with hepatitis B virus coinfection, low HCV viral load, low serum alanine aminotransferase, high serum aspartate aminotransferase, diabetes, and high pickled food consumption. Medical procedures were common transmission risk factors; however, lifestyle-associated risk factors, including intravenous drug abuse and tattoos or piercings, were more common in patients with HCV genotype 3 or 6. ConclusionsMost HCV-infected Han Chinese patients were IL28B genotype CC (rs12979860). HCV genotypes varied by geographic region, and disease characteristics differed according to HCV genotype. Relatively frequent detection of advanced liver disease may reflect limitations on access to antiviral therapy, and suggests that greater awareness of factors that influence HCV-associated disease may help avoid clinical complications and improve patient outcomes.

基金:

基金编号: 2008ZX10002-013 2008ZX10002-012 2012ZX10002003

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 3 区 医学
小类 | 3 区 胃肠肝病学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 胃肠肝病学
JCR分区:
出版当年[2012]版:
Q2 GASTROENTEROLOGY & HEPATOLOGY
最新[2024]版:
Q2 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100044, Peoples R China
通讯作者:
通讯机构: [1]Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100044, Peoples R China [*1]Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, 11 Xizhimen South St, Beijing 100044, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)